Under construction – not a live service
Sign in
Taking people in United StatesPhase 2

Tests a mild brain stimulation method for memory problems after stroke

Tests non-invasive brain stimulation on memory and thinking in adults with stroke-related cognitive impairment.

Plain-language title generated from the registry record
Registry title: tDCS for Post-Stroke Cognitive Impairment

Key facts

Where
Oklahoma City, United StatesSee the site
Phase
Phase 2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT06516588, who can take part

Where in United States

  • University of OklahomaOklahoma City, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Oklahoma
Trial code
NCT06516588
Record updated
10 October 2024
Original description
This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).Read full original descriptionShow less

Post-Stroke Cognitive Impairment: Neurovascular Mechanisms and Non-Invasive Brain Stimulation

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).

Inclusion: ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA <26).

Exclusion: previous neurosurgical procedure with craniectomy; clinically significant or unstable medical or psychiatric condition; history of relevant neurological diagnosis (e.g., epilepsy); severe visual impairment, hearing impairment, aphasia, neglect or dementia; diagnosis of severe depression; contraindications to tDCS (implanted brain medical devices).

ClinicalTrials.gov NCT06516588